Benzinga | Feb 24, 2021 04:30PM EST

Guardant Health Q4 EPS $(0.94) Misses $(0.57) Estimate, Sales $78.32M Beat $76.73M Estimate

Guardant Health (NASDAQ:GH) reported quarterly losses of $(0.94) per share which missed the analyst consensus estimate of $(0.57) by 64.91 percent. This is a 248.15 percent decrease over losses of $(0.27) per share from the same period last year. The company reported quarterly sales of $78.32 million which beat the analyst consensus estimate of $76.73 million by 2.07 percent. This is a 24.51 percent increase over sales of $62.90 million the same period last year.